Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

AEterna Zentaris Inc T.AEZ

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s): AEZS

AEterna Zentaris, Inc., is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology.
Price: $1.27 | Change: +$0.05 | % Change: +4.10%
Volume: 22,062 | Day High/Low: 1.27/1.22 | 52 Week High/Low: 2.20/1.04
top

Snapshot

Last Traded: April 17, 2014 11:58 Transaction Volume: 22,062
Open: $1.27 Previous Close: $1.22
Bid: $1.23 Ask: $1.30
Bid Size: 1,000 Ask Size: 2,000
Market Cap: $71.8m Shares Out: 56.5m
PE Ratio: 3.2 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest News

Medical marijuana update: Pot stocks down as SEC halts Growlife (PHOT)

After the high comes the crash.

Chris Parry   9 days ago
0 stars

Medical marijuana update: Tweed busts out of the gate, Chlormet halted on news

Tweed finds a solid valuation on listing debut.

Chris Parry   April 4, 2014
0 stars

Medical marijuana update: Chlormet opens up, GrowLife fumbles results

The wheat is beginning to separate from the chaff in the burgeoning junior medical marijuana industry.

Chris Parry   April 2, 2014
0 stars

Medical marijuana update: Southbridge is up 500%, but you can’t have any

Consultants and trade halts and vending machines: oh my!

Chris Parry   March 28, 2014
0 stars

Medical marijuana update: Satori strife, Affinor firms, Supreme on a run

Daytrader fear backwash is killing sector highs, but a couple of companies are sticking out as upward movers.

Chris Parry   March 27, 2014
0 stars

Latest Bullboard Posts

  • PP Closed

    0 stars

    Price firming up nice. $1.20 now. https://twitter.com/CndStockTrader

    2.5 stars


  • RE:new finance 1.15

    0.5 stars

    Quick close on this PP ... price won't stay at this level for very long. https://twitter.com/CndStockTrader

    2.5 stars


  • new finance 1.15

    0 stars

    1.15 finance with a freebie warrent.  new price to settle at 1.05-1.10 here factoring in a warrent premium, or is there reason for today...

    2.5 stars


  • RE:seekingalpha

    0 stars

    Very difficult one to forecast because of poor drug visibility. Strong balance sheet is very  positive.

    2.5 stars


  • level 2 at 3:00 pm

    0 stars

    # Orders Shares Bid Ask Shares # Orders 5 95000 0.500 0...

    4 stars